OSCR
OSCR's valuation appears fair, fundamentals are above averages and forward estimates point to earnings and revenue growth, though analyst coverage is limited and estimates vary widely.
OSCR vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 23x | 126x | 81% lower-81% |
| PE percentile | 7.1 | 51 | 86% lower-86% |
| EPS | $1.40 | -$2.08 | $3.48 higher+$3.48 |
| FCF | $4.3B | $451.9M | 859% higher+859% |
| Loading historical comparisons… | |||
OSCR’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Strong growth |
| Forward profitability | Stable |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
OSCR’s outlook is generally improving, though analyst coverage is limited.
OSCR PE Valuation
This table applies OSCR's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
OSCR Earnings Per Share
This chart tracks OSCR's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
OSCR Quarterly Revenue
This chart tracks OSCR's quarterly revenue over time and shows how sales are changing from year to year.
OSCR Free Cash Flow
This chart tracks OSCR's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
OSCR Total Shares
This chart tracks changes in OSCR's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
OSCR Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
OSCR PE vs Healthcare Sector
This chart compares OSCR's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
OSCR Weekly Price
This chart uses OSCR's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
OSCR Weekly Moving Averages
This chart compares OSCR's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
OSCR Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
TGTX
TGTX's valuation is historically cheap, fundamentals provide solid support, but weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.
TGTX vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 20x | 75x | 74% lower-74% |
| PE percentile | 37 | 50 | 25% lower-25% |
| EPS | $2.74 | -$0.72 | $3.46 higher+$3.46 |
| FCF | -$560K | -$129.1M | +$128.5M+$128.5M |
| Loading historical comparisons… | |||
TGTX’s earnings are above their historical averages, while its earnings multiple is lower.
TGTX Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly deteriorating |
| Forward earnings | Strong decline |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
TGTX’s outlook is mixed, with weaker expected earnings weighing on the picture.
TGTX PE Valuation
This table applies TGTX's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
TGTX Earnings Per Share
This chart tracks TGTX's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
TGTX Quarterly Revenue
This chart tracks TGTX's quarterly revenue over time and shows how sales are changing from year to year.
TGTX Free Cash Flow
This chart tracks TGTX's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
TGTX Total Shares
This chart tracks changes in TGTX's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
TGTX Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
TGTX PE vs Healthcare Sector
This chart compares TGTX's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
TGTX Weekly Price
This chart uses TGTX's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
TGTX Weekly Moving Averages
This chart compares TGTX's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
TGTX Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.